This is a Proprietary Laboratory Analyses (PLA) code, meaning that the code applies to only one unique lab test made by a specific manufacturer or performed by a specific lab. Report 0328U for CareView360 from Newstar Medical Laboratories LLC. The test screens for 120 or more drugs and metabolites (breakdown products) in a urine specimen using liquid chromatography with tandem mass spectrometry (LC–MS/MS). The evaluation includes an algorithmic analysis of the drugs and metabolites identified to report the presence or absence of risk for a significant adverse drug event (ADE). The procedure includes specimen validity testing.
For clinical responsibility, terminology, tips and additional info
start codify free trial.